http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0323303-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 1988-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1992-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1992-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0323303-B1 |
| titleOfInvention | Nicotinoyl piperazine derivatives, process for their preparation and their therapeutical use |
| abstract | The present invention relates, by way of novel industrial products, to (i) 4-aryl-1-nicotinoylpiperazines of the formula <IMAGE> (I) in which R1 and R2, which can be identical or different, each represent the hydrogen atom, a halogen atom (especially F, Cl or Br) or a CF3, C1-C4-alkyl, C1-C4-alkoxy or C2-C4-acyl group; and (ii) addition salts thereof. These products are useful in therapy as anticonvulsants. |
| priorityDate | 1987-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.